✦ LIBER ✦

Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: A meta-analysis

✍ Scribed by Ta-Chen Huang; Toby C. Campbell

Book ID: 119224469
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 479 KB
Volume: 38
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2011.10.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An economic analysis of dose dense weekl

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer

✍ Heather J. Dalton; Xinhua Yu; Lilian Hu; Daniel S. Kapp; Ivor Benjamin; Bradley 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 558 KB

A meta-analysis of paclitaxel-based chem

A meta-analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non-small-cell lung cancer

✍ Gao, Guanghui; Chu, Haiqing; Zhao, Lan; Gui, Tao; Xu, Qinghua; Shi, Jianping 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 321 KB

An economic analysis of intravenous carb

An economic analysis of intravenous carboplatin plus dose-dense weekly paclitaxel versus intravenous carboplatin plus every three-weeks paclitaxel in the upfront treatment of ovarian cancer

✍ H. Dalton; X. Yu; L. Hu; B. Monk; I. Benjamin; J. Chan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Randomized comparison of nab-paclitaxel

Randomized comparison of nab-paclitaxel weekly or every 3 weeks compared to docetaxel every 3 weeks as first-line therapy in patients (pts) with metastatic breast cancer (MBC)

✍ W. Gradishar; D. Krasnojon; S. Cheporov; A. Makhson; G. Manikhas; A. Clawson; P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Randomized, active-controlled, phase , d

Randomized, active-controlled, phase , dose-comparison study of NESP administered weekly or every 2 weeks in patients with solid tumors

✍ Glaspy, J; Jadeja, J; Justice, G; Kessler, J; Richards, D; Schwartzberg, L; O'By 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase 3 study comparing the use of docet

Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer

✍ Edgardo Rivera; Jaime A. Mejia; Banu K. Arun; Rosnie B. Adinin; Ronald S. Walter 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

## Abstract ## BACKGROUND Previous studies have evaluated 3‐week and weekly docetaxel schedules in patients with metastatic breast cancer (MBC). The varying efficacy results and toxicity profiles noted in these earlier studies led to a comparison of the schedules to determine which was safer and m